@emily_fri Bridging has been proven harmful in stable patients. Hard to imagine it is less harmful in critically ill patients. Hippocratic oath applies. https://t.co/jfLawIzZ1V
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2015 – May 2025Where it's discussed
-
X / Twitter69 posts
-
Facebook62 posts
-
News8 articles
-
Blogs8 articles
-
YouTube2 videos
AI synopsis
What people are saying
The overall tone shows a strong consensus supporting the trial's conclusion that avoiding routine bridging is safer for patients with atrial fibrillation, with posts using words like 'proven harmful' and 'confirmation of the evidence.' Several discussions reference how the study has changed or reinforced clinical practices, indicating high engagement and perceived impact in the medical community.
Most discussions endorse the findings of the BRIDGE trial, emphasizing the safety and benefits of not using bridging anticoagulation.
Multiple posts express high interest, referencing related studies and clinical implications with enthusiasm and detailed commentary.
Many discussions delve into methodological details, implications for practice, and references to specific trials, indicating deep engagement.
The discussions highlight the significant shift in clinical practice suggested by the trial, with some posts noting how it influences guidelines and treatment strategies.
Abstract in brief
- The study tested whether skipping bridging anticoagulation is just as safe (noninferior) to using low-molecular-weight heparin to prevent blood clots and whether it results in fewer serious bleeding events (superior).
- The trial involved over 1800 patients, comparing those who received bridging therapy with dalteparin to those who did not, stopping warfarin 5 days before their procedure and restarting it afterward.
- The results showed that not using bridging anticoagulation did not increase the risk of blood clots and significantly reduced the chance of major bleeding compared to bridging therapy.
Top posts
Most liked on X and BlueskyConsult article day 5 - stop bridging people!!
@michael22joseph Whether to bridge perioperatively is a separate question. Fortunately DOACs have made this a lot simpler. Here’s some ammo for your perspective for patients on warfarin… https://t.co/qBCHUy4cxI
ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170869 ref.2 Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. NEJM2015; 373: 823–833. PMID: 26095867
参考文献 https://t.co/iU182pYx7H
All mentions
Anticoagulation Strategies in Atrial Fibrillation Management
This Harvard Medical School video discusses anticoagulation in atrial fibrillation, focusing on patient selection, risk assessment with the CHA2DS2Vasc score, and bleeding risk management, emphasizing stroke prevention…
Reevaluating Perioperative Anticoagulation in Atrial Fibrillation Patients
Patients with atrial fibrillation face increased stroke risk. The BRIDGE trial compares safe management strategies for anticoagulation around surgery, showing no increased clot risk when skipping bridging therapy and…
4/7. En période courte, les chirurgiens ont bien réévalué la question. Ils ne faut pas bridger l'AOD pour une héparine ! L'HBPM : un pavé de l'enfer dans les soins? https://t.co/P5eowVRBAe https://t.co/QikyqLqvoE.
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | New England Journal of Medicine https://t.co/8ETPSztvGF
https://t.co/UiZQ25pWqm
RT @PharmacyToDose: #TrialOfTheDay for August 9th is the BRIDGE trial, published in August 2015 in @NEJM A less is more approach to antic…
RT @PharmacyToDose: #TrialOfTheDay for August 9th is the BRIDGE trial, published in August 2015 in @NEJM A less is more approach to antic…
#TrialOfTheDay for August 9th is the BRIDGE trial, published in August 2015 in @NEJM A less is more approach to anticoagulation Open-access article link: https://t.co/5lLYFqPn83 #pharmicu #cardiotwitter #twitterx #medtwitter #foamcc #meded #anticoagulation #some https://t.co/zgqgBOD0sG
RT @EzraTeitelbaum: @michael22joseph Whether to bridge perioperatively is a separate question. Fortunately DOACs have made this a lot simpl…
@michael22joseph Whether to bridge perioperatively is a separate question. Fortunately DOACs have made this a lot simpler. Here’s some ammo for your perspective for patients on warfarin… https://t.co/qBCHUy4cxI
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @javier20ch:
RT @djc795: @emily_fri Bridging has been proven harmful in stable patients. Hard to imagine it is less harmful in critically ill patients…
@emily_fri If no past h/o thromboemboli or low Chadsvasc, not a fan of bridging with heparin. Unless major concern of hypercoaguable state. https://t.co/dDLNXjDF5O
RT @djc795: @emily_fri Bridging has been proven harmful in stable patients. Hard to imagine it is less harmful in critically ill patients…
RT @djc795: @emily_fri Bridging has been proven harmful in stable patients. Hard to imagine it is less harmful in critically ill patients…
@emily_fri Bridging has been proven harmful in stable patients. Hard to imagine it is less harmful in critically ill patients. Hippocratic oath applies. https://t.co/jfLawIzZ1V
@DxRxEdu @UREssien @CKaneshiroMD We need an updated BRIDGE in the DOAC era. https://t.co/mH17IjsGr1
Some studies always stay young! A reminder of this fascinating study shared by our #chiefresident @AaronWalkerMD for the #morningreport #afib #CardioTwitter #MedTwitter Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | NEJM https://t.co/I6Sk6Rqldw
@rogguronium https://t.co/mDLZtjawZw
RT @cardio_dr_ys: ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170…
RT @cardio_dr_ys: ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170…
RT @cardio_dr_ys: ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170…
RT @cardio_dr_ys: ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170…
RT @cardio_dr_ys: ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170…
ref.1 Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142. PMID: 20170869 ref.2 Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. NEJM2015; 373: 823–833. PMID: 26095867
@jdrwilcox @spitinmemouf @IM_Crit_ Yes… we struggle to get IV heparin right on HDU/ICU with 1:1 nursing and plenty of vascular access! Of note the BRIDGE trial - https://t.co/i0Obye74nd
And used the landmark @NEJM BRIDGE trial to decide not to start LMWH for a patient with AFib admitted for a procedure https://t.co/P0vXTLfUqC (9/X)
RT @cardio_dr_ys: @S7hBv 有名どころとしてはこちらでしょうか。 Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation https://t.co/W61JV…
@S7hBv 有名どころとしてはこちらでしょうか。 Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation https://t.co/W61JVy8c01
This is from the BRIDGE trial https://t.co/isMng1GMfn
@GilbertTangMD @djc795 @mirvatalasnag @Argenscore @HarryDauerman @tnazifMD @TsuyoshiKaneko1 @lamelaspablo @ryankaple @M_Pompeu_Sa_MD @JACCJournals Agree, for those who haven’t, here it is: https://t.co/scpV0eDF9Z
I’m slightly extrapolating this and considering even higher risks for a pause - but happy to hear opinion https://t.co/ggClAlK4O9
The BRIDGE trial is a noninferiority trial enrolling 1884 patients and comparing subcutaneous injections of LMWH (lovenox) versus placebo in afib patients on warfarin who need to undergo surgery. https://t.co/OjeriR6vQx
RT @Ad_SotoMota: Ganó el BRIDGE! https://t.co/g7lMNTFjS0 Nos vemos el jueves! https://t.co/XNJTyyay1H
RT @Ad_SotoMota: Ganó el BRIDGE! https://t.co/g7lMNTFjS0 Nos vemos el jueves! https://t.co/XNJTyyay1H
Ganó el BRIDGE! https://t.co/g7lMNTFjS0 Nos vemos el jueves! https://t.co/XNJTyyay1H
Opción 1: ¿Hay que "puentear" (traslapar heparina y anticoagulantes) a los pacientes con fibrilación auricular antes de una cirugía? El estudio BRIDGE: https://t.co/g7lMNTFjS0
BRIDGE TRIAL
The earlier BRIDGE trial studied warfarin discontinuation and need for LMWH bridging in a perioperative setting which was also a non inferior study to placebo https://t.co/KrmayIgXDY
@ABsteward @bmj_latest Confirmation of BRIDGE? https://t.co/RFpeyJOv6q
Mark you Calendars! The next Perioperative Care Journal Club meeting - Wed., May 26 at 6:00 pm EDT - Dr. Hannah MacKenzie will discuss Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation (BRIDGE Trial). Very pleased to have Dr. James Douketis joining us.
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
RT @Bloodman: Consult article day 5 - stop bridging people!!
Consult article day 5 - stop bridging people!!
@economicexile That was periop right? https://t.co/XfDrcjV94L
In folks w/ afib, do we need to bridge anticoagulation peri-procedurally? Usually not! i.e. the BRIDGE trial and PAUSE study show pretty low rates of bleeding and few strokes just holding then restarting anticoagulation. https://t.co/ttGFE1eNIi https://t.co/VrmnNllNJC
@GilbertTangMD @djc795 @mirvatalasnag @Argenscore @HarryDauerman @tnazifMD @TsuyoshiKaneko1 @lamelaspablo @ryankaple @M_Pompeu_Sa_MD @JACCJournals In a RCT of AF patients no benefit of bridging was found, so definitely no bridging. https://t.co/4SzfwwUg1Q
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | NEJM https://t.co/yDI6A4WYPI
@Bloodman trained me well. Question whether bridging is necessary, especially for patients who have paroxysmal atrial fibrillation. BRIDGE trial showed non-inferiority of no AC vs. bridging AC for peri-operative procedures. #medtwitter https://t.co/vxFvqD4j8b
RT @pablolavados: Este es otro tema y datos contra-intuitivos a tener en cuenta en pacientes con #FA y #anticoagulados; no hacer terapia pu…
RT @pablolavados: Este es otro tema y datos contra-intuitivos a tener en cuenta en pacientes con #FA y #anticoagulados; no hacer terapia pu…
RT @pablolavados: Este es otro tema y datos contra-intuitivos a tener en cuenta en pacientes con #FA y #anticoagulados; no hacer terapia pu…
Este es otro tema y datos contra-intuitivos a tener en cuenta en pacientes con #FA y #anticoagulados; no hacer terapia puente con heparinas si se van a operar. @interneurona Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | NEJM https://t.co/XPFcRpfMiN
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | NEJM https://t.co/aTNMVVo6jI
参考文献 https://t.co/iU182pYx7H
@bogdienache @VPrasadMDMPH I guess they were that the program directors favored them? On the other hand, what was the evidence that work hours restrictions had net benefits that justified it as standard? I see it like the Douketis et al #NIFT of #bridginganticoagulation https://t.co/dnjHuAAN50
No es No. #bridge study (DOI: 10.1056/NEJMoa1501035) nos mostró que en paciente ACO por FA no valvular NO debemos hacer puente con HBPM peri-operatorio: Igual trombo/Mayor sangrado. ¿Y si la razón de ACO fuera Enfermedad Tromboembólica Venosa (ETV)?
DM
DF
B
ET
Y循
澤外
MA
TH
ち
Dم
CM
PP
MM
FG
LA
DL
DP
N
CG
DM
E
FM
AF
HC
EF
WF
UR
HF
PK
T
い
後P
色ガ
M
RB
お
HS
SG
ZC
DR
D
AM
SA
JA
TL
S
MG
AS
AA
CF
GB
PR
MF
SA
MS
AC
AN
S
AK
NF
AA
FS
PL
FO
TP
FB